-
On May 29, 2009, the Food and Drug Administration (FDA) granted tentative approval for generic lamivudine/zidovudine tablets 150 mg/300 mg indicated for treatment for Human Immunodeficiency Virus (HIV) in patients with or without Acquired Immunodeficiency Syndrome (AIDS).
-
The alarming number of young HIV-infected men who have sex with (MSM) who do not know they are infected is driving transmission in this disproportionately emerging population in the AIDS epidemic, the Centers for Disease Control and Prevention reports.
-
-
A new study with surprising results about the low percentage of HIV-infected inmates accessing antiretroviral therapy (ART) post-release could be seen as a model for following this population.
-
Research has found that combination antiretroviral therapies and studies showing superior benefits of some drugs over others have led to wide acceptance in recent years for two initial therapy regimens.
-
Female-controlled HIV prevention options are set to expand with the Food and Drug Administration (FDA) March 2009 approval of the second generation of the female condom manufactured by the Female Health Co.
-
A patient presented to an ED with a foreign body in her foot, but the ED physician didn't find anything even after doing an X-ray and exploring the wound. The next day, the radiologist read the X-ray and saw a foreign body.
-
Which medication mistakes are the most indefensible? "Those which are ordinarily avoidable, and simply the result of poor attentiveness on the part of the nurse," says Ann Robinson, MSN, RN, CEN, LNC, principal of Robinson Consulting, a Cambridge, MD-based legal nurse consulting company.
-
-
This issue of ED Nursing is a special issue on liability risks of emergency nurses.
